Jefferson Annual Brain Tumor Symposium: Contemporary Management of Brain and Spine Metastases

Jefferson Annual Brain Tumor Symposium: Contemporary Management of Brain and Spine Metastases is organized by Thomas Jefferson University (TJU) Office of Continuing Professional Development (OCPD) and will be held on Oct 30, 2026 at Jefferson Alumni Hall, Philadelphia, Pennsylvania, United States of America.

Description:
Join the Jefferson Department of Neurosurgery for this engaging, multidisciplinary educational program focused on the latest advances in the diagnosis and treatment of metastatic brain and spine tumors. This innovative activity brings together nationally recognized experts in neurosurgery, neuro-oncology, radiation oncology, medical oncology, nursing, and supportive care to explore emerging therapies, evolving treatment strategies, and collaborative approaches that are transforming patient outcomes.

Through keynote presentations, expert panel discussions, breakout sessions, and an interactive multidisciplinary tumor board, participants will gain practical, evidence-based insights into contemporary management of CNS metastases, spine metastases, precision oncology, radiation strategies, supportive care, and translational research.

Designed for physicians, advanced practice providers, nurses, and other healthcare professionals involved in neuro-oncology care, this symposium highlights Jefferson’s commitment to advancing excellence in patient-centered brain tumor care and fostering collaboration across specialties. Additionally, the symposium has been planned for the target audience in the following specialties: Neurosurgery, Radiation Oncology, Neuro-Oncology, Medical Oncology and Orthopedics, with a disease focus in Central Nervous System (CNS) Metastases involving the Brain and Spine.

Objectives:
At the conclusion of this activity, healthcare team members will be able to:

1. Examine recent advancements and emerging research directions in the multidisciplinary management of brain and spine metastases.
2. Evaluate evolving systemic therapy strategies, including immunotherapy, targeted therapy, antibody-drug conjugates, and clinical trial approaches, and their implications for patients with CNS metastatic disease.
3. Analyze contemporary applications of surgery, stereotactic radiosurgery, fractionated radiation, spine stabilization, and separation surgery for patients with complex brain and spine metastases.
4. Discuss updates in neuropathology, molecular diagnostics, and tumor classification that inform prognosis, treatment selection, and multidisciplinary decision-making for metastatic CNS tumors.
5. Differentiate disease progression from treatment-related effects, including radiation necrosis, pseudoprogression, leptomeningeal disease, and post-treatment radiographic change, using clinical, radiographic, pathologic, and molecular information.
6. Integrate the roles of neurosurgery, radiation oncology, medical oncology, neuropathology, spine oncology, advanced practice providers, neuropsychology, palliative care, and supportive oncology into coordinated, patient-centered care plans.
7. Employ effective interprofessional communication strategies that merge clinical observations, specialty expertise, imaging interpretation, pathology/molecular data, and patient goals to optimize care for patients with brain and spine metastases.
8. Apply principles of collaboration, mutual respect, trust, integrity, and ethical practice when working with members of the healthcare team to deliver high-quality, patient centered care for patients with metastatic CNS disease.